Veterinary Medicines

Canaural øredråber

Authorised
  • Prednisolone
  • Diethanolamine fusidate
  • Framycetin sulfate
  • Nystatin
Download as PDF

Product identification

Medicine name:
Canaural øredråber
Canaural øredråber
Active substance:
  • Prednisolone
  • Diethanolamine fusidate
  • Framycetin sulfate
  • Nystatin
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Prednisolone
    2.50
    milligram(s)
    /
    1.00
    gram(s)
  • Diethanolamine fusidate
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • Framycetin sulfate
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear drops
Withdrawal period by route of administration:
  • Auricular use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Dechra Veterinary Products A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Leo Pharma A/S
  • Genera d.d.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 06436
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."